{"id":8265,"date":"2026-01-01T18:18:58","date_gmt":"2026-01-01T16:18:58","guid":{"rendered":"https:\/\/inprojournal.org\/?page_id=8265"},"modified":"2026-02-04T10:34:21","modified_gmt":"2026-02-04T08:34:21","slug":"2024-1-6","status":"publish","type":"page","link":"https:\/\/inprojournal.org\/en\/2024-1-6\/","title":{"rendered":"2024-1-6"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"734\" height=\"1024\" src=\"https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-734x1024.jpg\" alt=\"\" class=\"wp-image-3609\" style=\"width:217px;height:302px\" srcset=\"https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-734x1024.jpg 734w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-215x300.jpg 215w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-768x1071.jpg 768w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-1101x1536.jpg 1101w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-1468x2048.jpg 1468w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-scaled.jpg 1835w\" sizes=\"auto, (max-width: 734px) 100vw, 734px\" \/><\/figure>\n\n\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-small-font-size\">Theory and practice of intellectual property<br>\u2116 1 \/ 2024<\/p>\n\n\n\n<p class=\"has-small-font-size\">ISSN (Print) 2308-0361<br>ISSN (Online) 2519-2744<\/p>\n\n\n\n<div class=\"wp-block-buttons has-custom-font-size is-content-justification-left is-layout-flex wp-container-core-buttons-is-layout-fdcfc74e wp-block-buttons-is-layout-flex\" style=\"font-size:10px\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-black-color has-text-color has-custom-font-size wp-element-button\" href=\"https:\/\/drive.google.com\/file\/d\/1TNLaJkXMKyxdFEtksAzVToHZx4Rl08ID\/view\" style=\"border-radius:10px;font-size:10px\" target=\"_blank\" rel=\"noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"14\" height=\"14\" class=\"wp-image-362\" style=\"width: 14px;\" src=\"https:\/\/test.inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153.png\" alt=\"\" srcset=\"https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153.png 512w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153-300x300.png 300w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153-150x150.png 150w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153-450x450.png 450w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153-106x106.png 106w, https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153-80x80.png 80w\" sizes=\"auto, (max-width: 14px) 100vw, 14px\" \/> PDF (Ukrainian)<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-small-font-size\">DOI: <a href=\"https:\/\/doi.org\/10.33731\/12024.300902\">https:\/\/doi.org\/10.33731\/12024.300902<\/a><\/p>\n\n\n\n<p class=\"has-small-font-size\">Submitted&nbsp; &nbsp;&nbsp; 2024-02-09<br>Accepted &nbsp;&nbsp; &nbsp; 2024-02-12<br>Published &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024-03-29<\/p>\n\n\n\n<div style=\"height:8px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/inprojournal.org\/wp-content\/uploads\/2025\/11\/CC-2.png\" alt=\"\" class=\"wp-image-6960\" style=\"width:131px;height:auto\"\/><\/figure>\n\n\n\n<p class=\"has-small-font-size\"><\/p>\n\n\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-small-font-size\"><\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p class=\"has-medium-font-size\"><strong>International threats to access to treatment: implementation of TRIPS-plus in Ukraine and the world<\/strong><\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>Iryna Iakovets<\/strong><br>Doctor of Legal Sciences\/Dr. Habil. (Law), Senior Researcher, Head of the Center for Legal Support of Science and Technology Development of the Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine<br>Ukraine<br><a href=\"https:\/\/orcid.org\/0000-0002-1022-3115\">https:\/\/orcid.org\/0000-0002-1022-3115<\/a><\/p>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>Abstract<br><\/strong>Effective realization of the right to health is conditioned on the availability and affordability of health products. Local manufacturing development is significantly dependent on the intellectual property rules used by the country. Balancing between the intellectual property rights protection and the right to health is rarely on the side of the right to health, and the most suffering from such an imbalance are patients. The article analyses the provisions of TRIPS-plus (supplementary protection certificates, data exclusivity, patent linkage, measures of customs authorities to facilitate the protection of intellectual property rights during the movement of goods across the customs border of Ukraine) in the context of their impact on the market of medicines and access to treatment. The TRIPS Agreement, while establishing minimum standards for the protection of intellectual property rights, reserves the right of WTO members to resort to higher protection measures at the level of national jurisdictions. The provisions of TRIPS-plus create barriers to access to treatment by promoting the formation of monopolies in the pharmaceutical market, high prices for medicines, and blocking the entry of generics into the market. Ukraine has implemented many of the TRIPS-plus provisions being pushed in international agreements by developed countries, including patent term extensions in the form of supplementary protection certificates (harmonized to EU standards), 5-year data exclusivity of clinical trials data, patent linkage, and border measures. At the same time, the approach to TRIPS plus measures differs between countries. Similarly, patent linkage is not implemented in the European Union. While data exclusivity protection exists in the US, EU, and Turkey, there is no such TRIPS provision in many other countries, like Argentina, Brazil, Bolivia, and Ecuador. The author concludes that it is necessary to rethink legislative approaches to the protection of intellectual property rights to medicinal products, with a view that the right to health should be prioritized over intellectual property rights protection. Moreover, the author suggests that in a situation of war, Ukraine should fully use all the avenues that the TRIPS Agreement flexible provisions can offer and use the opportunity to protect its essential security interests.<\/p>\n\n\n\n<p><strong>Keywords: <\/strong>abuse of rights, intellectual property rights, access to medicines, TRIPS plus<\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>References<\/strong><\/p>\n\n\n\n<p>\u0423\u0433\u043e\u0434\u0430 \u043f\u0440\u043e \u0442\u043e\u0440\u0433\u043e\u0432\u0435\u043b\u044c\u043d\u0456 \u0430\u0441\u043f\u0435\u043a\u0442\u0438 \u043f\u0440\u0430\u0432 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u0432\u0456\u0434 15 \u043a\u0432\u0456\u0442\u043d\u044f 1994 \u0440.<br><a href=\"https:\/\/zakon.rada.gov.ua\/laws\/show\/981_018\">https:\/\/zakon.rada.gov.ua\/laws\/show\/981_018<\/a><\/p>\n\n\n\n<p>Pfizer, BioNTech and Moderna making $1,000 profit every second while world\u2019s poorest countries remain largely unvaccinated.<br><a href=\"https:\/\/www.oxfam.org\/en\/press-releases\/pfizer-biontech-and-moderna-making-1000-profit-every-second-while-worlds-poorest\">https:\/\/www.oxfam.org\/en\/press-releases\/pfizer-biontech-and-moderna-making-1000-profit-every-second-while-worlds-poorest<\/a><\/p>\n\n\n\n<p>\u041a\u0430\u0448\u0438\u043d\u0446\u0435\u0432\u0430 \u041e. \u042e. \u041f\u043e\u0437\u0438\u0446\u0456\u044f \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0442\u0430 \u0420\u0430\u0434\u0456 \u0422\u0420\u0406\u041f\u0421 \u0449\u043e\u0434\u043e \u043d\u0435\u043e\u0431\u0445\u0456\u0434\u043d\u043e\u0441\u0442\u0456 \u0437\u0430\u043f\u0440\u043e\u0432\u0430\u0434\u0436\u0435\u043d\u043d\u044f \u0432\u0438\u043a\u043b\u044e\u0447\u0435\u043d\u044c \u0437 \u043c\u043e\u043d\u043e\u043f\u043e\u043b\u0456\u0457 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u043d\u0430 \u0447\u0430\u0441 \u043f\u0430\u043d\u0434\u0435\u043c\u0456\u0457. (11.05.2021).<br><a href=\"https:\/\/medcom.unba.org.ua\/publications\/6573-poziciya-ukraini-ta-radi-trips-shodo-neobhidnosti-zaprovadzhennya-viklyuchen-z-monopolii-intelektual-noi-vlasnosti-na-chas-pandemii.html\">https:\/\/medcom.unba.org.ua\/publications\/6573-poziciya-ukraini-ta-radi-trips-shodo-neobhidnosti-zaprovadzhennya-viklyuchen-z-monopolii-intelektual-noi-vlasnosti-na-chas-pandemii.html<\/a><\/p>\n\n\n\n<p>Pashkov V. M. The impact of the legal regime of intellectual property protection in the pharmaceutical market . Wiadomosci Lekarskie. 2016. T. LXIX, nr 3 (cz. II). P. 582\u2013586.<\/p>\n\n\n\n<p>\u041f\u0440\u043e \u0432\u043d\u0435\u0441\u0435\u043d\u043d\u044f \u0437\u043c\u0456\u043d \u0434\u043e \u0434\u0435\u044f\u043a\u0438\u0445 \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0432\u0447\u0438\u0445 \u0430\u043a\u0442\u0456\u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0449\u043e\u0434\u043e \u0440\u0435\u0444\u043e\u0440\u043c\u0438 \u043f\u0430\u0442\u0435\u043d\u0442\u043d\u043e\u0433\u043e \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0432\u0441\u0442\u0432\u0430: \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 21 \u043b\u0438\u043f\u043d\u044f 2020 \u0440. \u2116 816-IX.<br><a href=\"https:\/\/zakon.rada.gov.ua\/go\/816-20\">https:\/\/zakon.rada.gov.ua\/go\/816-20<\/a><\/p>\n\n\n\n<p>\u041f\u0440\u043e \u043e\u0445\u043e\u0440\u043e\u043d\u0443 \u043f\u0440\u0430\u0432 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u043e\u0434\u0438 \u0456 \u043a\u043e\u0440\u0438\u0441\u043d\u0456 \u043c\u043e\u0434\u0435\u043b\u0456: \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 23 \u0433\u0440\u0443\u0434\u043d\u044f 1993 \u0440. \u2116 3769-XII.<br><a href=\"https:\/\/zakon.rada.gov.ua\/laws\/show\/3687-12\">https:\/\/zakon.rada.gov.ua\/laws\/show\/3687-12 <\/a><\/p>\n\n\n\n<p>Regulation (EC) No 469\/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products.<br><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex%3A32009R0469\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex%3A32009R0469<\/a><\/p>\n\n\n\n<p>\u0406\u0432\u0430\u0445\u043d\u0435\u043d\u043a\u043e \u042e., \u0404\u0444\u0456\u043c\u0447\u0443\u043a \u041e.,&nbsp; \u041f\u043e\u043b\u0456\u0449\u0443\u043a \u041c. \u0417\u0432\u0456\u0442 \u0449\u043e\u0434\u043e \u0422\u0420\u0406\u041f\u0421+ \u043f\u043e\u043b\u043e\u0436\u0435\u043d\u044c \u0432 \u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u043e\u043c\u0443 \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0432\u0441\u0442\u0432\u0456 \u0442\u0430 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0456\u0439 \u0449\u043e\u0434\u043e \u0457\u0445 \u043f\u043e\u043c\u2019\u044f\u043a\u0448\u0435\u043d\u043d\u044f. \u041a\u0438\u0457\u0432, 2017. 112 \u0441.<br><a href=\"https:\/\/network.org.ua\/wp-content\/uploads\/2020\/06\/Report_for_print.pdf\">https:\/\/network.org.ua\/wp-content\/uploads\/2020\/06\/Report_for_print.pdf<\/a><\/p>\n\n\n\n<p>\u041f\u0440\u043e \u043b\u0456\u043a\u0430\u0440\u0441\u044c\u043a\u0456 \u0437\u0430\u0441\u043e\u0431\u0438: \u0417\u0430\u043a\u043e\u043d \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 04 \u043a\u0432\u0456\u0442\u043d\u044f 1996 \u0440. \u2116 123\/96-\u0412\u0420.<br><a href=\"https:\/\/zakon.rada.gov.ua\/go\/123\/96-%D0%B2%D1%80\">https:\/\/zakon.rada.gov.ua\/go\/123\/96-%D0%B2%D1%80<\/a><\/p>\n\n\n\n<p>IFPMA, Data Exclusivity: Encouraging Development of New Medicines, 2011, 84 p.<br><a href=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/01\/i2023_IFPMA_2011_Data_Exclusivity__En_Web.pdf\">https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/01\/i2023_IFPMA_2011_Data_Exclusivity__En_Web.pdf<\/a><\/p>\n\n\n\n<p>\u0413\u0443\u0440\u0433\u0443\u043b\u0430 \u041e. \u041f\u0430\u0442\u0435\u043d\u0442\u043d\u0430 \u0443\u0432\u2019\u044f\u0437\u043a\u0430 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456 \u0441\u043b\u0443\u0436\u0438\u0442\u044c \u0454\u0434\u0438\u043d\u0456\u0439 \u0446\u0456\u043b\u0456 \u2014 \u0448\u0442\u0443\u0447\u043d\u043e\u043c\u0443 \u043f\u0440\u043e\u0434\u043e\u0432\u0436\u0435\u043d\u043d\u044e \u043f\u0430\u0442\u0435\u043d\u0442\u043d\u043e\u0457 \u043c\u043e\u043d\u043e\u043f\u043e\u043b\u0456\u0457 \u0444\u0430\u0440\u043c\u043a\u043e\u043c\u043f\u0430\u043d\u0456\u0439, \u042e\u0440\u0438\u0434\u0438\u0447\u043d\u0430 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430, 15.11.2023.<br><a href=\"https:\/\/pravo.ua\/patentna-uv-iazka-v-ukraini-sluzhyt-iedynii-tsili-shtuchne-prodovzhennia-patentnoi-monopolii-farmkompanii\/\">https:\/\/pravo.ua\/patentna-uv-iazka-v-ukraini-sluzhyt-iedynii-tsili-shtuchne-prodovzhennia-patentnoi-monopolii-farmkompanii\/<\/a><\/p>\n\n\n\n<p>\u041c\u0438\u0442\u043d\u0438\u0439 \u043a\u043e\u0434\u0435\u043a\u0441 \u0423\u043a\u0440\u0430\u0457\u043d\u0438 \u0432\u0456\u0434 13.03.2012 \u0440. \u2116 4495-VI.<br><a href=\"https:\/\/zakon.rada.gov.ua\/go\/4495-17\">https:\/\/zakon.rada.gov.ua\/go\/4495-17<\/a><\/p>\n\n\n\n<p>\u0423\u0433\u043e\u0434\u0430 \u043f\u0440\u043e \u0430\u0441\u043e\u0446\u0456\u0430\u0446\u0456\u044e \u043c\u0456\u0436 \u0423\u043a\u0440\u0430\u0457\u043d\u043e\u044e, \u0437 \u043e\u0434\u043d\u0456\u0454\u0457 \u0441\u0442\u043e\u0440\u043e\u043d\u0438, \u0442\u0430 \u0404\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0438\u043c \u0421\u043e\u044e\u0437\u043e\u043c, \u0404\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0438\u043c \u0441\u043f\u0456\u0432\u0442\u043e\u0432\u0430\u0440\u0438\u0441\u0442\u0432\u043e\u043c \u0437 \u0430\u0442\u043e\u043c\u043d\u043e\u0457 \u0435\u043d\u0435\u0440\u0433\u0456\u0457 \u0456 \u0457\u0445\u043d\u0456\u043c\u0438 \u0434\u0435\u0440\u0436\u0430\u0432\u0430\u043c\u0438-\u0447\u043b\u0435\u043d\u0430\u043c\u0438, \u0437 \u0456\u043d\u0448\u043e\u0457 \u0441\u0442\u043e\u0440\u043e\u043d\u0438 \u0432\u0456\u0434 21 \u0431\u0435\u0440\u0435\u0437\u043d\u044f 2014 \u0440.<br><a href=\"https:\/\/zakon.rada.gov.ua\/go\/984_011\">https:\/\/zakon.rada.gov.ua\/go\/984_011<\/a><\/p>\n\n\n\n<p>\u041c\u043e\u0441\u043a\u0430\u043b\u044e\u043a \u041d. \u0411.&nbsp; \u0422\u0435\u043e\u0440\u0435\u0442\u0438\u0447\u043d\u0456 \u043f\u0435\u0440\u0435\u0434\u0443\u043c\u043e\u0432\u0438 \u0442\u0430 \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0456 \u0430\u0441\u043f\u0435\u043a\u0442\u0438 \u043f\u0430\u0440\u0430\u043b\u0435\u043b\u044c\u043d\u043e\u0433\u043e \u0456\u043c\u043f\u043e\u0440\u0442\u0443 \u0432 \u0441\u0438\u0441\u0442\u0435\u043c\u0456 \u0440\u0435\u0430\u043b\u0456\u0437\u0430\u0446\u0456\u0457 \u043f\u0440\u0430\u0432 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u043d\u0430 \u043b\u0456\u043a\u0430\u0440\u0441\u044c\u043a\u0456 \u0437\u0430\u0441\u043e\u0431\u0438. \u0427\u0430\u0441\u043e\u043f\u0438\u0441 \u0410\u043a\u0430\u0434\u0435\u043c\u0456\u0457 \u0430\u0434\u0432\u043e\u043a\u0430\u0442\u0443\u0440\u0438 \u0423\u043a\u0440\u0430\u0457\u043d\u0438. 2013. \u2116 3.<br><a href=\"http:\/\/nbuv.gov.ua\/UJRN\/Chaau_2013_3_16\">http:\/\/nbuv.gov.ua\/UJRN\/Chaau_2013_3_16<\/a><\/p>\n\n\n\n<p>Medicins Sans Frontieres, Ukraine: Open Letter: Urgent action by Johnson &#038; Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis, 21.09.2023.<br><a href=\"https:\/\/www.msfaccess.org\/ukraine-open-letter-urgent-action-johnson-johnson-needed-improve-equitable-access-bedaquiline-based\">https:\/\/www.msfaccess.org\/ukraine-open-letter-urgent-action-johnson-johnson-needed-improve-equitable-access-bedaquiline-based<\/a><\/p>\n\n\n\n<p>\u0406\u0432\u0430\u043d\u0435\u043d\u043a\u043e \u0414. \u0414., \u0413\u043b\u0443\u0449\u0435\u043d\u043a\u043e \u041d. \u0412. \u041f\u0440\u0430\u0432\u043e\u0432\u0456 \u0430\u0441\u043f\u0435\u043a\u0442\u0438 \u0432\u043f\u043b\u0438\u0432\u0443 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u043d\u0430 \u0434\u043e\u0441\u0442\u0443\u043f\u043d\u0456\u0441\u0442\u044c \u043b\u0456\u043a\u0430\u0440\u0441\u044c\u043a\u0438\u0445 \u0437\u0430\u0441\u043e\u0431\u0456\u0432 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456. \u041f\u0440\u0430\u0432\u043e\u0432\u0438\u0439 \u0447\u0430\u0441\u043e\u043f\u0438\u0441 \u0414\u043e\u043d\u0431\u0430\u0441\u0443. 2021. \u21163 (76). \u0421. 39-44.<br><a href=\"https:\/\/doi.org\/10.32366\/2523-4269-2021-76-3-39-44\">https:\/\/doi.org\/10.32366\/2523-4269-2021-76-3-39-44<\/a><\/p>\n\n\n\n<p>\u041a\u0430\u0448\u0438\u043d\u0446\u0435\u0432\u0430 \u041e., \u0406\u043e\u043b\u043a\u0456\u043d \u042f. \u0414\u043e\u0442\u0440\u0438\u043c\u0430\u043d\u043d\u044f \u0431\u0430\u043b\u0430\u043d\u0441\u0443 \u0456\u043d\u0442\u0435\u0440\u0435\u0441\u0456\u0432 \u0441\u0443\u0441\u043f\u0456\u043b\u044c\u0441\u0442\u0432\u0430 \u0442\u0430 \u0456\u043d\u0442\u0435\u0440\u0435\u0441\u0456\u0432 \u0441\u0443\u0431\u2019\u0454\u043a\u0442\u0456\u0432 \u043f\u0430\u0442\u0435\u043d\u0442\u043d\u0438\u0445 \u043f\u0440\u0430\u0432 \u043f\u0440\u0438 \u043a\u043e\u0434\u0438\u0444\u0456\u043a\u0430\u0446\u0456\u0457 \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0432\u0441\u0442\u0432\u0430 \u0443 \u0441\u0444\u0435\u0440\u0456 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. \u0422\u0435\u043e\u0440\u0456\u044f \u0456 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456.&nbsp; 2021. \u2116 6. \u0421. 87-93.<br><a href=\"https:\/\/doi.org\/10.33731\/62021.249080\">https:\/\/doi.org\/10.33731\/62021.249080<\/a><\/p>\n\n\n\n<p>Said \u041c. The Impact of \u2018TRIPS-Plus\u2019 Rules on the Use of TRIPS Flexibilities: Dealing with the Implementation Challenges. Access to Medicines and Vaccines, 28.10.2021. \u0420. 297\u2013327.<br><a href=\"https:\/\/doi.org\/10.1007\/978-3-030-83114-1_11\">https:\/\/doi.org\/10.1007\/978-3-030-83114-1_11<\/a><\/p>\n\n\n\n<p>The role of intellectual property rights on access to medicines in the WHO African region: 25\u2009years after the TRIPS agreement. &nbsp;BMC Public Health. &nbsp;2021.<br><a href=\"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-10374-y\">https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-10374-y<\/a><\/p>\n\n\n\n<p>\u041a\u0430\u0448\u0438\u043d\u0446\u0435\u0432\u0430 \u041e. \u042e., \u0422\u0440\u043e\u0444\u0438\u043c\u0435\u043d\u043a\u043e \u041c. \u041c.&nbsp; \u041f\u0440\u0430\u0432\u043e\u0432\u0456 \u043c\u0435\u0445\u0430\u043d\u0456\u0437\u043c\u0438 \u0440\u043e\u0437\u0448\u0438\u0440\u0435\u043d\u043d\u044f \u0434\u043e\u0441\u0442\u0443\u043f\u0443 \u0434\u043e \u043b\u0456\u043a\u0443\u0432\u0430\u043d\u043d\u044f \u0437\u0430 \u0443\u043c\u043e\u0432 \u043f\u0430\u043d\u0434\u0435\u043c\u0456\u0457 \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456 \u0442\u0430 \u0441\u0432\u0456\u0442\u0456. \u041c\u0435\u0434\u0438\u0447\u043d\u0435 \u043f\u0440\u0430\u0432\u043e. 2020.&nbsp; \u2116 2(26). \u0421. 34-48.<br><a href=\"https:\/\/doi.org\/10.25040\/medicallaw2020.02.034\">https:\/\/doi.org\/10.25040\/medicallaw2020.02.034<\/a><\/p>\n\n\n\n<p>\u0414\u043e\u0440\u043e\u0448\u0435\u043d\u043a\u043e \u041e. \u0424., \u0422\u0432\u0435\u0440\u0435\u0437\u0435\u043d\u043a\u043e \u041e. \u041e. \u0414\u043e\u0434\u0430\u0442\u043a\u043e\u0432\u0430 \u043e\u0445\u043e\u0440\u043e\u043d\u0430 \u043f\u0440\u0430\u0432 \u043d\u0430 \u0432\u0438\u043d\u0430\u0445\u043e\u0434\u0438: \u043f\u0440\u043e\u0431\u043b\u0435\u043c\u0438 \u043f\u0440\u0430\u0432\u043e\u0432\u043e\u0433\u043e \u0440\u0435\u0433\u0443\u043b\u044e\u0432\u0430\u043d\u043d\u044f \u0442\u0430 \u043c\u043e\u0436\u043b\u0438\u0432\u0456 \u0448\u043b\u044f\u0445\u0438 \u0432\u0438\u0440\u0456\u0448\u0435\u043d\u043d\u044f. \u0410\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u0456 \u043f\u0440\u043e\u0431\u043b\u0435\u043c\u0438 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0433\u043e, \u0456\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0456\u0439\u043d\u043e\u0433\u043e, \u0456\u043d\u0442\u0435\u0440\u043d\u0435\u0442 \u043f\u0440\u0430\u0432\u0430 \u0442\u0430 \u0406\u0422 \u043f\u0440\u0430\u0432\u0430: \u043c\u0430\u0442\u0435\u0440\u0456\u0430\u043b\u0438 \u0441\u044c\u043e\u043c\u043e\u0457 \u0412\u0441\u0435\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u043e\u0457 \u043d\u0430\u0443\u043a\u043e\u0432\u043e-\u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u043e\u0457 \u043a\u043e\u043d\u0444\u0435\u0440\u0435\u043d\u0446\u0456\u0457 (\u043c. \u041b\u044c\u0432\u0456\u0432, 29 \u0432\u0435\u0440\u0435\u0441\u043d\u044f 2022 \u0440.). \u041b\u044c\u0432\u0456\u0432: \u041b\u044c\u0432\u0456\u0432\u0441\u044c\u043a\u0438\u0439 \u043d\u0430\u0446\u0456\u043e\u043d\u0430\u043b\u044c\u043d\u0438\u0439 \u0443\u043d\u0456\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442 \u0456\u043c. \u0406. \u0424\u0440\u0430\u043d\u043a\u0430, 2023. \u0421. 94-99.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Theory and practice of intellectual property\u2116 1 \/ 2024 ISSN (Print) 2308-0361ISSN (Online) 2519-2744 DOI: https:\/\/doi.org\/10.33731\/12024.300902 Submitted&nbsp; &nbsp;&nbsp; 2024-02-09Accepted &nbsp;&nbsp; &nbsp; 2024-02-12Published &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024-03-29 International threats to access to treatment: implementation of TRIPS-plus in Ukraine and the world Iryna IakovetsDoctor of Legal Sciences\/Dr. Habil. (Law), Senior Researcher, Head of the Center for Legal Support of Science [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-8265","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/8265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/comments?post=8265"}],"version-history":[{"count":4,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/8265\/revisions"}],"predecessor-version":[{"id":8415,"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/pages\/8265\/revisions\/8415"}],"wp:attachment":[{"href":"https:\/\/inprojournal.org\/en\/wp-json\/wp\/v2\/media?parent=8265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}